Nu Skin Enterprises

Nu Skin Enterprises, Inc. is a holding company, which engages in the development and distribution of personal care products and nutritional supplements. It operates through the following segments: Mainland China, Americas, South Korea, Southeast Asia/Pacific, EMEA, Japan, Hong Kong/Taiwan, Nu Skin Other, Manufacturing, Grow Tech, and Rhyz Other. The first seven segments represent the Nu Skin geographic operations. The last three segments deal with Rhyz investments. Its brands include Nu Skin and Pharmanex. The company was founded by Blake M. Roney, Sandra N. Tillotson, and Steven J. Lund in 1984 and is headquartered in Provo, UT.

Earnings data Q2 2023

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Nu Skin Enterprises, Inc. is a holding company, which engages in the development and distribution of beauty and wellness solutions. It operates through the following segments: Mainland China, Americas, South Korea, Southeast Asia/Pacific, EMEA, Japan, Hong Kong/Taiwan, Nu Skin Other, Manufacturing, and Rhyz Other. The company was founded by Blake M. Roney, Sandra N. Tillotson, and Steven J. Lund in 1984 and is headquartered in Provo, UT.

Nu Skin (NUS) witnesses robust consumer growth during second-quarter 2020. The company raises sales guidance for the quarter.

Nu Skin (NUS) Revises Q2 Sales View Upward, Stock Rises

Shares of Nu Skin Enterprises Inc. NUS, +0.57% jumped more than 11% in the extended session Wednesday after the maker of supplements and personal care products estimated that its second-quarter sales will be between $603 million and $608 million, above its previous forecast.

Nu Skin stock rallies 11% after company's better Q2 sales outlook

PROVO, Utah, July 1, 2020 /PRNewswire/ -- Nu Skin Enterprises, Inc. (NYSE: NUS) today reported it estimates revenue for the second quarter of 2020 to be approximately $603 to $608 million. The company previously forecasted second-quarter revenue of $520 to $550 million. The company will...

Nu Skin Enterprises Reports Estimated Second-Quarter Revenue Above Previous Guidance

B&G Foods

Helen of Troy

United Natural Foods

Consumer staples sector shows resilience amid the pandemic due to strong demand for food and other essentials. Efforts to keep pace with consumer trends should bolster the sector's growth.

Tap Market Potential With These 4 Consumer Staples Stocks

Nu Skin (NUS) seems to be a good value pick, as it has decent revenue metrics to back up its earnings, and is seeing solid earnings estimate revisions as well.

Why Nu Skin (NUS) Could Be a Top Value Stock Pick

Clorox

Flowers Foods

Kimberly-Clark

Medifast

At a juncture where many companies have suspended dividends due to the coronavirus crisis, we have picked five consumer staple stocks, which are continuing with dividend payments.

5 Consumer Staple Dividend Stocks to Enrich Your Portfolio

Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock?

Nu Skin (NUS) Up 11.9% Since Last Earnings Report: Can It Continue?

Nu Skin (NUS) has been seeing improved trends in Mainland China as coronavirus-induced restrictions are being lifted in the region.

Here's Why Nu Skin (NUS) Stock is Up More Than 40% in a Month

As of late, it has definitely been a great time to be an investor in Nu Skin Enterprises

Nu Skin Enterprises' Shares March Higher, Can It Continue?

NUS vs. PORBF: Which Stock Is the Better Value Option?

Coty

Estee Lauder

Cosmetics Industry Outlook Prospects Dimmed by Coronavirus Woes

Both Q1 results and 2020 guidance came in significantly higher than analyst estimates.

Why Nu Skin Enterprises Blasted Nearly 30% Higher on Thursday

Why Nu Skin Enterprises Blasted Nearly 30% Higher on Thursday (NUS)

Nu Skin's (NUS) first-quarter 2020 results reflect lower earnings and sales. Foreign currency headwinds and reduced sales leaders in Mainland China hurt results.

Nu Skin's (NUS) Q1 Earnings Beat Estimates, Decline Y/Y

Nu Skin Enterprises, Inc. (NUS) CEO Ritch Wood on Q1 2020 Results - Earnings Call Transcript

Nu Skin (NUS) delivered earnings and revenue surprises of 50.00% and 6.90%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Nu Skin Enterprises (NUS) Surpasses Q1 Earnings and Revenue Estimates

Multi-level marketing company Nu Skin Enterprises Inc. NUS, +0.36% shares rose nearly 8% in the extended session Wednesday, after the company beat earnings and revenue expectations.

Nu Skin stock rises after earnings beat

Impacts from foreign currency headwinds are likely to get reflected on Nu Skin's (NUS) first-quarter 2020 results. Also, restrictions on travel amid coronavirus are a concern.

Here's How Nu Skin (NUS) is Placed Ahead of Q1 Earnings

AbbVie

Bunge

Chevron

DXC Technology

Patterson Companies

Steep market declines in 2020 have not only been brutal on returns; they've also presented income investors with a conundrum.

8 Safe High-Yield Dividend Stocks Offering 5% or More

Why Is Nu Skin (NUS) Down 37.4% Since Last Earnings Report?

Nu Skin (NUS) anticipates sales in Mainland China to decline 20-25% in 2020. The company puts meetings on hold in the region due to the coronavirus outbreak.

Will Nu Skin Mainland China Woes Worsen Due to Coronavirus?

In trading on Thursday, shares of NU Skin Enterprises, Inc. (NYSE:NUS) were yielding above the 6% mark based on its quarterly dividend (annualized to $1.5), with the stock changing hands as low as $24.34 on the day.

NU Skin Enterprises Breaks Above 6% Yield Territory

Inter Parfums

Coronavirus-led worries weigh on the guidance of these cosmetic stocks due to reduced global travel and sluggish traffic.

Coronavirus Steals Glitter Off These 3 Cosmetic Stocks

The coronavirus outbreak in China is badly hurting the maker of personal care products.

Why Nu Skin Enterprises Stock Fell Today

Nu Skin's (NUS) fourth-quarter 2019 results reflect lower earnings and sales. Further, management expects the coronavirus outbreak to hurt Mainland China sales in 2020.

News for Nu Skin Enterprises Stock (NUS)